These devices function by delivering insulin subcutaneously, mimicking the physiological secretion of the pancreas. The most advanced versions integrate a sensor that monitors glucose levels in real-time, providing constant data to the system.

The core innovation lies in intelligent algorithms that automatically adjust insulin doses. This reduces manual intervention and the risk of hypoglycemia. CSAPG is providing specific training to ensure patients can effectively manage carbohydrate counting and device maintenance.